Cancer registries
czech english
Impact of Oncotype DX testing on treatment decisions
in patients with breast cancer in the Czech Republic
(decision impact study)


The Oncotype DX® project is guaranteed by the Czech Society for Oncology at the CzMA. Technological and analytical background and project management is provided by the Institute of Biostatistics and Analyses Ltd, a spin-off company of the Masaryk University. Please contact the project managers or helpdesk in case of your interest or questions on the project.

Institute of Biostatistics and Analyses Ltd